Improve Enrollment News Today

The United States occupies a leadership position in clinical advancements, in terms of pharmaceuticals, medical devices, innovative care processes and interventional techniques.

The United States occupies a leadership position in clinical advancements, in terms of pharmaceuticals, medical devices, innovative care processes and interventional techniques. At the...

As the 2024 elections approach, federal agencies are working to finalize rules and regulations ahead of the Congressional Review Act (CRA)...

Last month, in the last advisory opinion issued by the Office of Inspector General (“OIG”) in 2023 – Advisory Opinion No. 23-11 (the “Opinion”) – OIG “blessed” an arrangement involving...

The Food and Drug Administration (FDA) has issued new draft guidance, Postmarketing Approaches to Obtain Data on Populations Underrepresented in Clinical Trials for Drugs and Biological...

The Food and Drug Omnibus Reform Act, signed into law by President Biden on Dec. 29, 2022, includes provisions intended to modernize clinical...

/PRNewswire/ -- The Diversity Now Protocol by RxE2 provides a pharmacist-centered approach for compliance with Section V, Categories 4 and 5 of the US Food and...

It is well known that certain ethnic groups are routinely underrepresented in global clinical trials. But another data set now shows that some of...

In the waning days of 2022, Congress passed the omnibus spending legislation to provide funding for the federal government through September 2023…

We don’t have to wait for federal guidance, additional DHT, or new innovations. We have the tools to begin to address the lack of trust and...